Physician profile
Michael D Payne
NPI 1306968342
$3,107.42
in general payments reported to CMS, 2019-2025
8 companies · $29.62 in 2025
The $29.62 reported for 2025 was less than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,107 · 2020: $517 · 2021: $657 · 2022: $46.57 · 2023: $525 · 2024: $225 · 2025: $29.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692 · Education: $87.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.34 |
| Education | $87.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $2,633.80 | 2019-2024 | Invisalign, Vivera Retainers, Touch Up |
| Lightforce Orthodontics, INC. | $191.84 | 2023-2025 | |
| 3m Company | $102.62 | 2019-2022 | |
| Colgate Oral Pharmaceuticals, INC. | $87.40 | 2024 | |
| American Orthodontics Corporation | $41.38 | 2023 | Master Series, Radiance, Empower-Ceramic |
| Ormco Corporation | $21.19 | 2022 | |
| Solventum Corporation | $14.70 | 2025 | Filtek |
| Philips North America LLC | $14.49 | 2024 | (Dn4) Ptb - Kids |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.